ProCE Banner Activity

Könnten Virostatika bei der Prophylaxe oder Behandlung von Long COVID eine Rolle spielen?

Clinical Thought

Dr. Cristina Mussini erörtert, ob sich antivirale COVID-19-Medikamente bei der Prophylaxe und/oder Behandlung von Long COVID als nützlich erweisen, von Clinical Care Options (CCO)

Released: December 05, 2022

Expiration: December 04, 2023

Share

Faculty

Cristina Mussini

Cristina Mussini, MD

Director of Infectious Diseases Clinics
Professor of Infectious Diseases
University of Modena School of Medicine
Modena, Italy

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Cristina Mussini, MD

Director of Infectious Diseases Clinics
Professor of Infectious Diseases
University of Modena School of Medicine
Modena, Italy

Dr. Cristina Mussini: Consultant/Beraterin/Sprecherin:: AbbVie, Angelini, Gilead Sciences, Janssen, MSD, Pfizer, Roche, ViiV Healthcare; Forscherin: Gilead Sciences, Janssen, MSD, ViiV Healthcare.